Diabetes mellitus and the risk of dementia

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neurology

• Publication date

  1999-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1212/WNL.53.9.1937PMID 10599765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Boston Naming Test

  2001cited by this paper
• The Beck Depression Inventory

  2001cited by this paper
• Head injury

  2000cited by this paper
• Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study.

  1999cited by this paper
• Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease.

  1999cited by this paper
• Low-Dose Growth Hormone Treatment with Diet Restriction Accelerates Body Fat Loss, Exerts Anabolic Effect and Improves Growth Hormone Secretory Dysfunction in Obese Adults

  1999cited by this paper
• Rates and risk factors for dementia and Alzheimer’s disease

  1999cited by this paper
• Report of the second dementia with Lewy body international workshop

  1999cited by this paper
• Are sex and educational level independent predictors of dementia and Alzheimer’s disease? Incidence data from the PAQUID project

  1999cited by this paper
• [Epidemiology of Alzheimer's disease].

  1999cited by this paper
• Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

  1998cited by this paper
• Modelling age-specific risk: application to dementia.

  1998cited by this paper
• Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.

  1998cited by this paper
• Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.

  1998cited by this paper
• Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: a three-year follow-up.

  1998cited by this paper
• Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein.

  1998cited by this paper
• Corticobasal Ganglionic Degeneration and Progressive Supranuclear Palsy Presenting with Cognitive Decline

  1998cited by this paper
• A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

  1998cited by this paper
• Incidence and risk of dementia. The Rotterdam Study.

  1998cited by this paper
• The Physiology and Pharmacology of Melatonin in Humans

  1998cited by this paper
• Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

  1998cited by this paper
• Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

  1998cited by this paper
• Cognitive decline is faster in Lewy body variant than in Alzheimer's disease

  1998cited by this paper
• Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

  1998cited by this paper
• Clinical presentation and pharmacological therapy in corticobasal degeneration.

  1998cited by this paper
• Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions

  1998cited by this paper
• [Dementia rating scale].

  1997cited by this paper
• Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging.

  1997cited by this paper
• Educational Level and Neuropsychological Heterogeneity in Dementia of the Alzheimer Type

  1997cited by this paper
• Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.

  1997cited by this paper
• Is the earlier age at onset of schizophrenia in males a confounded finding?

  1997cited by this paper
• Risk of dementia among persons with diabetes mellitus: a population-based cohort study.

  1997cited by this paper
• Alzheimer's disease after remote head injury: an incidence study.

  1997cited by this paper
• Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects

  1997cited by this paper
• Very Old Women at Highest Risk of Dementia and Alzheimer's Disease

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• A population-based analysis of qualitative features of the neuropsychological test performance of individuals with dementia of the Alzheimer type: Implications for individuals with questionable dementia.

  1997cited by this paper
• Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

  1997cited by this paper
• Prevalence of very mild to severe dementia in Denmark

  1997cited by this paper
• Risk Factors for Clinically Diagnosed Alzheimer's Disease: A Case-Control Study of a Greek Population

  1997cited by this paper
• Cognitive Models That Predict Physician Judgments of Capacity to Consent in Mild Alzheimer's Disease

  1997cited by this paper
• Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study.

  1997cited by this paper
• Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.

  1997cited by this paper
• Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease.

  1997cited by this paper
• Incidence and risk factors of vascular dementia and Alzheimer′s disease in a defined elderly Japanese population: The Hisayama Study(一般住民中の高齢者における脳血管性痴呆アルツハイマー病の発症率と危険因子の検討: 久山町研究)

  1997cited by this paper
• The Association Of Antihypertensive Agents with MRI White Matter Findings and with Modified Mini‐Mental State Examination in Older Adults

  1997cited by this paper
• HEAD INJURY AND THE RISK OF ALZHEIMER'S DISEASE: A CASE CONTROL STUDY

  1997cited by this paper
• Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

  1997cited by this paper
• Consistency of Physician Judgments of Capacity to Consent in Mild Alzheimer's Disease

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture.

  1997cited by this paper
• Executive control and the comprehension of medical information by elderly retirees.

  1997cited by this paper
• Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.

  1997cited by this paper
• Dementia Disorders in a Birth Cohort Followed From Age 85 to 88: The Influence of Mortality, Refusal Rate, and Diagnostic Change on Prevalence

  1997cited by this paper
• Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan

  1997cited by this paper
• Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.

  1997cited by this paper
• Can the blood pressure predict cognitive task performance in a healthy population sample?

  1997cited by this paper
• Predictors of mortality in patients diagnosed with probable Alzheimer's disease

  1996cited by this paper
• Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

  1996cited by this paper
• Estrogen replacement therapy and risk of Alzheimer disease.

  1996cited by this paper
• Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

  1996cited by this paper
• Cortical ballooned neurons in progressive supranuclear palsy.

  1996cited by this paper
• 15-year longitudinal study of blood pressure and dementia.

  1996cited by this paper
• Apolipoprotein‐E Genotyping of Diabetic Dementia Patients: Is Diabetes Rare in Alzheimer's Disease?

  1996cited by this paper
• Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease

  1996cited by this paper
• Dementia with Lewy bodies

  1996cited by this paper
• [Risk factors in Alzheimer's dementia].

  1996cited by this paper
• Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks?

  1996cited by this paper
• Risikofaktoren der Alzheimer-Demenz

  1996cited by this paper
• Neurodegenerative disorders with extensive tau pathology: A comparative study and review

  1996cited by this paper
• A clinical profile of corticobasal degeneration presenting as primary progressive aphasia.

  1996cited by this paper
• Epidemiology of Alzheimer's disease and current possibilities for prevention

  1996cited by this paper
• Unusual clinical presentations of cortical‐basal ganglionic degeneration

  1996cited by this paper
• Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review

  1996cited by this paper
• Executive dysfunction in early Alzheimer's disease.

  1996cited by this paper
• The Effects of Antihypertensive Treatment on Cognitive Function: Results from the HOPE Study

  1996cited by this paper
• Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards.

  1996cited by this paper
• Altered β-APP Metabolism After Head Injury and its Relationship to the Aetiology of Alzheimer’s Disease

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Low blood pressure and dementia in elderly people: the Kungsholmen project

  1996cited by this paper
• β-Amyloid-mediated vasoactivity and vascular endothelial damage

  1996cited by this paper
• Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study.

  1996cited by this paper
• Predictors of mortality in the prospective Dubbo study of Australian elderly.

  1996cited by this paper
• Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration

  1996cited by this paper
• The Theoretical and Technical Foundations of Health Measurement

  1996cited by this paper
• Widespread cytoskeletal pathology characterizes corticobasal degeneration.

  1995cited by this paper
• Age-specific incidence of Alzheimer's disease in a community population.

  1995cited by this paper
• Marital status, change in marital status, and mortality in middle-aged British men.

  1995cited by this paper
• Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline.

  1995cited by this paper
• Head injury as a risk factor in Alzheimer's disease.

  1995cited by this paper
• Relationship between lifetime occupation and parietal flow

  1995cited by this paper
• Contributions of anterior cingulate cortex to behaviour.

  1995cited by this paper
• Hormonal status affects the reactivity of the cerebral vasculature.

  1995cited by this paper
• A PET study of the functional neuroanatomy of writing impairment in Alzheimer's disease. The role of the left supramarginal and left angular gyri.

  1995cited by this paper
• The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study.

  1995cited by this paper
• Brain systems for encoding and retrieval of auditory-verbal memory. An in vivo study in humans.

  1995cited by this paper
• Predictors of survival with Alzheimer's disease: a community-based study

  1995cited by this paper

• IGROOVE: Protocol for a randomized, controlled, single-blind trial of dance intervention in older adults with subjective cognitive decline.

  2026cites this paper
• Heat therapy in individuals at risk for Alzheimer’s disease—methods for a randomized controlled trial

  2026cites this paper
• Exercise Suppresses Insulin Resistance: A Potential Mechanism for Improving the Interaction Between Type 2 Diabetes and Alzheimer's Disease.

  2026cites this paper
• The Association Between Diabetic Retinopathy Severity and Dementia Risk: A TriNetX Longitudinal Cohort Study.

  2026cites this paper
• Associations Between Diabetes Mellitus and Neurodegenerative Diseases

  2025influential citation
• Peripheral Inflammation and Insulin Resistance: Their Impact on Blood–Brain Barrier Integrity and Glia Activation in Alzheimer’s Disease

  2025cites this paper
• A Longitudinal Investigation of Prediabetes, Diabetes, HbA1c and Cognitive Trajectories Among Cognitively Unimpaired Individuals

  2025cites this paper
• Insurance type and risk of dementia diagnosis after traumatic brain injury: a study of 267 473 US civilians from 2000 to 2022

  2025cites this paper
• BDNF Levels and Cognitive Function in Patients with Type 2 Diabetes Treated with SGLT2 Inhibitors

  2025cites this paper
• Potential multiple disease progression pathways in female patients with Alzheimer’s disease inferred from transcriptome and epigenome data of the dorsolateral prefrontal cortex

  2025cites this paper
• Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits

  2025cites this paper
• Maternal Diet and Vulnerability to Cognitive Impairment in Adulthood: Possible Link with Alzheimer’s Disease?

  2025cites this paper
• The cross-sectional study of assessment of cognitive status in patients with poor glycemic control and good glycemic control of diabetes mellitus

  2025cites this paper
• Metabolomic signatures of cognitive function in a type 2 Diabetes-Enriched cohort

  2025cites this paper
• ApoE4 Upregulates GSK‐3β to Aggravate Alzheimer‐Like Pathologies and Cognitive Impairment in Type 2 Diabetic Mice

  2025cites this paper
• The brain-joint axis: links between osteoarthritis and neurodegenerative disorders in aging.

  2025cites this paper
• Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer’s Disease and Parkinson’s Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies

  2025cites this paper
• Insulin Resistance as a Mediator of Physical Activity's Effects on Beta-Amyloid Accumulation and Tau Phosphorylation: A scoping review.

  2025cites this paper
• Rhamnan Sulfate from the Seaweed Monostroma nitidum May Improve Cognitive Impairment Caused by Hyperglycemia

  2025cites this paper
• Regional variability of the impact of cardiometabolic diseases on incident dementia in United States Medicare beneficiaries

  2025cites this paper
• Traumatic Brain Injury as a Precursor to Neurodegenerative Diseases: Mechanisms Linking TBI to Alzheimer’s Disease

  2025cites this paper
• Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors

  2025cites this paper
• ASSOCIATION OF DIABETES MELLITUS WITH REACTION TIME, COGNITIVE FUNCTION AND PHYSICAL FITNESS

  2025cites this paper
• High Glucose Concentration on the Metabolic Activity of C6 Glia Cells: Implication in Alzheimer’s Disease

  2025cites this paper
• Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer’s Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids

  2025influential citation
• Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease

  2025cites this paper
• The Role of Inflammation, Oxidative Stress, Neuronal Damage, and Endothelial Dysfunction in the Neuropathology of Cognitive Complications in Diabetes: A Moderation and Mediation Analysis

  2025cites this paper
• Developing non-invasive molecular markers for early risk assessment of Alzheimer’s disease

  2025cites this paper
• Evaluating the Link Between Cardiovascular Risk and Alzheimer’s Disease: A Comprehensive Case-Control Study in Castilla y León, Spain

  2025cites this paper
• Scientometric analysis and historical review of diabetic encephalopathy research: Trends and hotspots (2004-2023)

  2025cites this paper
• SGLT2 inhibitors versus DPP-4 inhibitors and dementia risk in type 2 diabetes: A meta-analysis of cohort studies.

  2025cites this paper
• Bibliometric Analysis of the Epidemiological Research on Alzheimer’s Disease Treatment

  2025cites this paper
• Mechanisms underlying cognitive impairment and management strategies in type 2 diabetes

  2025cites this paper
• Increased risk of dementia and its subtypes following various forms of acquired brain injury: a meta-analysis and systematic review.

  2025cites this paper
• Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative Review

  2025cites this paper
• Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes

  2025cites this paper
• The influence of diabetic retinopathy on the risk of dementia: A nationwide cohort study

  2025cites this paper
• Bibliometric analysis of global research trends on the relationship between alzheimer’s disease and type 2 diabetes mellitus

  2025cites this paper
• Systemic lipid and glucose modulation differentially affects cognitive function and neuroinflammation in a mouse model of Alzheimer’s disease

  2025cites this paper
• Impaired insulin receptor function alters psychiatric behaviors without affecting circadian rhythms in a mouse model of Alzheimer's disease

  2025cites this paper
• Associations Between Traumatic Brain Injury Characteristics and Memory Outcomes: Insights from the Health and Retirement Study

  2025cites this paper
• Investigate the Relationship between Thyroid Function and Cognitive Dysfunction in Patients with Type 2 Diabetes Mellitus

  2024cites this paper
• Taohe Chengqi decoction improves diabetic cognitive dysfunction by alleviating neural stem cell senescence through HIF1α-driven metabolic signaling.

  2024cites this paper
• Differences in brain spindle density during sleep between patients with and without type 2 diabetes

  2024cites this paper
• Type 2 Diabetes Mellitus and Neurodegenerative Disorders: The Mitochondrial Connection.

  2024cites this paper
• Glycated Hemoglobin A1c Time in Range and Dementia in Older Adults With Diabetes

  2024cites this paper
• The Role of the Neural Exposome as a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer’s Disease and Related Dementias

  2024cites this paper
• True or False? Alzheimer's disease is Type 3 Diabetes: Evidences from Bench to Bedside.

  2024cites this paper
• Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth.

  2024cites this paper
• Providemus alz: Ubiquitous Screening of Preclinical Alzheimer's Disease with Consumer-grade Technologies

  2024cites this paper
• Time trends in Alzheimer’s disease mortality attributable to metabolic risks and smoking in China from 1990 to 2019: an age-period-cohort analysis

  2024cites this paper
• In Vivo and Computational Studies on Sitagliptin’s Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer’s Disease

  2024cites this paper
• Traumatic Brain Injury and Alzheimer’s Disease Biomarkers: A Systematic Review of Findings from Amyloid and Tau Positron Emission Tomography

  2024cites this paper
• Pathology and Treatments of Alzheimer’s Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes

  2024cites this paper
• Dose-Dependent Attenuation of the Efficacy of Clitoria ternatea by Cobalt Oxide Nanoparticles Against Diabetes-Induced Cognitive Impairment

  2024cites this paper
• Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease

  2024influential citation
• Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study

  2024cites this paper
• The Inhibition Effect of Epigallocatechin-3-Gallate on the Co-Aggregation of Amyloid-β and Human Islet Amyloid Polypeptide Revealed by Replica Exchange Molecular Dynamics Simulations

  2024cites this paper
• Fatty acid amides present in Camembert cheese improved cognitive decline after oral administration in mice.

  2024cites this paper
• A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer’s disease, and their co-morbidities

  2024cites this paper
• Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach

  2024cites this paper
• A Closer Look at the Perivascular Unit in the Development of Enlarged Perivascular Spaces in Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus

  2024cites this paper
• A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome

  2024cites this paper
• Changes in Brain Structure and Function in a Multisport Cohort of Retired Female and Male Athletes, Many Years after Suffering a Concussion: Implications for Neuroplasticity and Neurodegenerative Disease Pathogenesis

  2024cites this paper
• Moving Towards a Medicine of Dance: A Scoping Review of Characteristics of Dance Interventions Targeting Older Adults and a Theoretical Framework

  2024cites this paper
• Daily fluctuations in blood glucose with normal aging are inversely related to hippocampal synaptic mitochondrial proteins

  2024cites this paper
• Novel targets and therapies of metformin in dementia: old drug, new insights

  2024cites this paper
• Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: a population-based study.

  2024cites this paper
• A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome

  2024cites this paper
• Effect of selenium nanoparticles conjugated vildagliptin on cognitive dysfunction associated with diabetes mellitus

  2024cites this paper
• Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.

  2024cites this paper
• Sex Disparity in the Association of Metabolic Syndrome with Cognitive Impairment

  2024cites this paper
• Neuroinflammation induced by amyloid-forming pancreatic amylin: Rationale for a mechanistic hypothesis.

  2024cites this paper
• Experimental laboratory models as tools for understanding modifiable dementia risk

  2024cites this paper
• The impact of maternal smoking during pregnancy and the age of smoking initiation on incident dementia: A prospective cohort study

  2024cites this paper
• The menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases.

  2024cites this paper
• Effects of antidiabetic agents on platelet characteristics with implications in Alzheimer's disease: Mendelian randomization and colocalization study

  2024cites this paper
• Socioeconomic status and physical activity disparities in older adults: Implications for COVID-19 related diabetes cognitive dysfunction

  2024cites this paper
• MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review

  2024cites this paper
• Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort

  2023cites this paper
• Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding

  2023cites this paper
• Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia

  2023influential citation
• Resistance and Resilience to Alzheimer's Disease.

  2023cites this paper
• To investigate the association of serum osteocalcin with cognitive functional status in patients with type 2 diabetes: A systematic review with meta-analysis

  2023cites this paper
• Insulin resistance induces earlier initiation of cognitive dysfunction mediated by cholinergic deregulation in a mouse model of Alzheimer's disease

  2023cites this paper
• Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus.

  2023cites this paper
• Single Versus Repetitive Traumatic Brain Injury: Current Knowledge on the Chronic Outcomes, Neuropathology and the Role of TDP-43 Proteinopathy

  2023cites this paper
• Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK

  2023cites this paper
• Traumatic brain injury and Alzheimer’s Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)

  2023cites this paper
• Protoplasmic Perivascular Astrocytes Play a Crucial Role in the Development of Enlarged Perivascular Spaces in Obesity, Metabolic Syndrome, and Type 2 Diabetes Mellitus

  2023cites this paper
• Mitochondria and Oxidative Stress as a Link between Alzheimer’s Disease and Diabetes Mellitus

  2023cites this paper
• Toward Prevention and Reduction of Alzheimer’s Disease

  2023influential citation
• Association between pre-diabetes or diabetes and cognitive impairment in a community-dwelling older population: Bushehr Elderly Health (BEH) program

  2023cites this paper
• Why Is Iron Deficiency/Anemia Linked to Alzheimer’s Disease and Its Comorbidities, and How Is It Prevented?

  2023cites this paper
• Predictive factors for Alzheimer’s disease progression: a comprehensive retrospective analysis of 3,553 cases with 211 months follow-up

  2023cites this paper
• Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice.

  2023cites this paper
• Neuroprotective effects of terpenoids against streptozotocin-nicotinamide-induced diabetic rats: An in silico, in vitro and in vivo study.

  2023cites this paper
• The role of autophagy in the treatment of type II diabetes and its complications: a review

  2023cites this paper
• Oxidative Stress in Health and Disease

  2023cites this paper
• Differentiating the influence of sedentary behavior and physical activity on brain health in late adulthood.

  2023cites this paper